Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease

References

• Liddell K. Choosing a dermatological hero for the millennium. Hippocrates of Cos (460-377 BC). Clin Exp Dermatol. 2000 Jan;25(1):86–88.
   PubMedGoogle Scholar
• Cottin V. Pulmonary fibrosis: “idiopathic” is not “cryptogenic”. Eur Respir J. 2019 Mar;53(3):1802314.
   PubMedGoogle Scholar
• Crystal RG, Fulmer JD, Roberts WC, et al. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Inter Med. 1976 Dec;85(6):769–788.
   PubMed Web of Science ®Google Scholar
• American Thoracic S, European Respiratory S. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002 Jan 15;165(2):277–304.
   PubMedGoogle Scholar
• Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15;188(6):733–748.
   PubMed Web of Science ®Google Scholar
• Wolters PJ, Blackwell TS, Eickelberg O, et al. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med. 2018 Feb;6(2):154–160.
   PubMedGoogle Scholar
• Thannickal VJ, Wells A, Kolb M. Idiopathic pulmonary fibrosis: idiopathic no more? Lancet Respir Med. 2018 Feb;6(2):84–85.
   PubMedGoogle Scholar
• Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994 Feb;18(2):136–147.
   PubMed Web of Science ®Google Scholar
• Sumikawa H, Johkoh T, Ichikado K, et al. Nonspecific interstitial pneumonia: histologic correlation with high-resolution CT in 29 patients. Eur J Radiol. 2009 Apr;70(1):35–40.
   PubMedGoogle Scholar
• Todd NW, Marciniak ET, Sachdeva A, et al. Organizing pneumonia/non-specific interstitial pneumonia overlap is associated with unfavorable lung disease progression. Respir Med. 2015 Nov;109(11):1460–1468.
   PubMedGoogle Scholar
• Travis WD, Hunninghake G, King TE Jr., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008 Jun 15;177(12):1338–1347.
   PubMed Web of Science ®Google Scholar
• Arrossi AV. Pulmonary pathology in rheumatic disease. Clin Chest Med. 2019 Sep;40(3):667–677.
   PubMed Web of Science ®Google Scholar
• Mira-Avendano I, Abril A, Burger CD, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clin Proc. 2019 Feb;94(2):309–325.
   PubMedGoogle Scholar
• Romagnoli M, Nannini C, Piciucchi S, et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur Respir J. 2011;38(2):384–391.
   PubMed Web of Science ®Google Scholar
• Solomon JJ, Olson AL, Fischer A, et al. Scleroderma lung disease. Eur Respir Rev. 2013 Mar 1;22(127):6–19.
   PubMedGoogle Scholar
• Franks TJ, Galvin JR. Smoking-related “interstitial” lung disease. Arch Pathol Lab Med. 2015 Aug;139(8):974–977.
   PubMedGoogle Scholar
• Marten K, Milne D, Antoniou KM, et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol. 2009 Jul;19(7):1679–1685.
   PubMedGoogle Scholar
• Flaherty KR, Fell C, Aubry MC, et al. Smoking-related idiopathic interstitial pneumonia. Eur Respir J. 2014 Sep;44(3):594–602.
   PubMedGoogle Scholar
• Skeoch S, Weatherley N, Swift AJ, et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med. 2018 Oct 15;7(10):356.
   PubMed Web of Science ®Google Scholar
• Kalisz KR, Ramaiya NH, Laukamp KR, et al. Immune checkpoint inhibitor therapy-related pneumonitis: patterns and management. Radiographics. 2019 Nov-Dec;39(7):1923–1937.
   PubMedGoogle Scholar
• Azadeh N, Limper AH, Carmona EM, et al. The role of infection in interstitial lung diseases: a review. Chest. 2017 Oct;152(4):842–852.
   PubMedGoogle Scholar
• Vasakova M, Morell F, Walsh S, et al. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017 Sep 15;196(6):680–689.
   PubMed Web of Science ®Google Scholar
• Churg A, Sin DD, Everett D, et al. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009 Dec;33(12):1765–1770.
   PubMedGoogle Scholar
• Vourlekis JS, Schwarz MI, Cool CD, et al. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med. 2002 Apr 15;112(6):490–493.
   PubMed Web of Science ®Google Scholar
• Majewski S, Piotrowski W. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci. 2015 Dec 10;11(6):1179–1188.
   PubMedGoogle Scholar
• Cozzi D, Moroni C, Addeo G, et al. Radiological patterns of lung involvement in inflammatory bowel disease. Gastroenterol Res Pract. 2018;2018:5697846.
   PubMedGoogle Scholar
• Cinetto F, Scarpa R, Rattazzi M, et al. The broad spectrum of lung diseases in primary antibody deficiencies. Eur Respir Rev. 2018 Sep 30;27(149):180019.
   PubMedGoogle Scholar
• Bierry G, Boileau J, Barnig C, et al. Thoracic manifestations of primary humoral immunodeficiency: a comprehensive review. Radiographics. 2009 Nov;29(7):1909–1920.
   PubMed Web of Science ®Google Scholar
• Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med. 2005 Nov 1;172(9):1146–1152.
   PubMedGoogle Scholar
• Borie R, Le Guen P, Ghanem M, et al. The genetics of interstitial lung diseases. Eur Respir Rev. 2019 Sep 30;28(153):190053.
   PubMedGoogle Scholar
• Bennett D, Mazzei MA, Squitieri NC, et al. Familial pulmonary fibrosis: clinical and radiological characteristics and progression analysis in different high resolution-CT patterns. Respir Med. 2017 May;126:75–83.
   PubMed Web of Science ®Google Scholar
• Miyagawa-Hayashino A, Sonobe M, Kubo T, et al. Non-specific interstitial pneumonia as a manifestation of graft-versus-host disease following pediatric allogeneic hematopoietic stem cell transplantation. Pathol Int. 2010 Feb;60(2):137–142.
   PubMedGoogle Scholar
• Schlemmer F, Chevret S, Lorillon G, et al. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respir Med. 2014 Oct;108(10):1525–1533.
   PubMed Web of Science ®Google Scholar
• Scallan C, Venado A, Han L, et al. Recurrent pulmonary fibrosis in a lung allograft secondary to de novo antisynthetase syndrome. Ann Am Thorac Soc. 2020 Jul;17(7):901–904.
   PubMedGoogle Scholar
• Hinze AM, Lin CT, Hussien AF, et al. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma. Rheumatology (Oxford). 2020 Apr 1;59(4):790–798.
   PubMedGoogle Scholar
• Wells AU, Cottin V. Nonspecific interstitial pneumonia: time to be more specific? Curr Opin Pulm Med. 2016 Sep;22(5):450–455.
   PubMedGoogle Scholar
• Chai GT, Tan TC, Lee YS, et al. Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore. Singapore Med J. 2020 Jun;61(6):302–307.
   PubMed Web of Science ®Google Scholar
• De Sadeleer LJ, Meert C, Yserbyt J, et al. Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases. Chest. 2018 Jun;153(6):1416–1423.
   PubMed Web of Science ®Google Scholar
• Dodia N, Amariei D, Kenaa B, et al. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease. Respir Med. 2021;179:106333.
   PubMedGoogle Scholar
• Floyd R. Organization of pneumonic exudates. Am J Med Sci. 1922;163(4):527–548.
   Google Scholar
• Davison AG, Heard BE, McAllister WA, et al. Cryptogenic organizing pneumonitis. Q J Med. 1983 Summer;52(207):382–394.
   PubMedGoogle Scholar
• Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med. 1985 Jan 17;312(3):152–158.
   PubMed Web of Science ®Google Scholar
• Cordier JF. Organising pneumonia. Thorax. 2000 Apr;55(4):318–328.
   PubMed Web of Science ®Google Scholar
• Roberton BJ, Hansell DM. Organizing pneumonia: a kaleidoscope of concepts and morphologies. Eur Radiol. 2011 Nov;21(11):2244–2254.
   PubMedGoogle Scholar
• Myers JL, Katzenstein AL. Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans-organizing pneumonia. Am J Pathol. 1988 Jul;132(1):102–109.
   PubMedGoogle Scholar
• Todd NW, Atamas SP, Luzina IG, et al. Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2015 Aug;9(4):411–418.
   PubMed Web of Science ®Google Scholar
• Lee JW, Lee KS, Lee HY, et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol. 2010 Oct;195(4):916–922.
   PubMedGoogle Scholar
• Wang Y, Jin C, Wu CC, et al. Organizing pneumonia of COVID-19: time-dependent evolution and outcome in CT findings. PLoS One. 2020;15(11):e0240347.
   PubMedGoogle Scholar
• Romero S, Barroso E, Rodriguez-Paniagua M, et al. Organizing pneumonia adjacent to lung cancer: frequency and clinico-pathologic features. Lung Cancer. 2002 Feb;35(2):195–201.
   PubMedGoogle Scholar
• Pardo J, Panizo A, Sola I, et al. Prognostic value of clinical, morphologic, and immunohistochemical factors in patients with bronchiolitis obliterans-organizing pneumonia. Hum Pathol. 2013 May;44(5):718–724.
   PubMedGoogle Scholar
• Schwaiblmair M, Behr W, Haeckel T, et al. Drug induced interstitial lung disease. Open Respir Med J. 2012;6(1):63–74.
   PubMedGoogle Scholar
• Nishino M, Hatabu H, Hodi FS, et al. Drug-related pneumonitis in the era of precision cancer therapy. JCO Precis Oncol. 2017;1. https://doi.org/10.1200/PO.17.00026. PubMed PMID: 32913972.
   PubMed Web of Science ®Google Scholar
• Castro CY. ARDS and diffuse alveolar damage: a pathologist’s perspective. Semin Thorac Cardiovasc Surg. 2006 Spring;18(1):13–19.
   PubMedGoogle Scholar
• Cardinal-Fernandez P, Lorente JA, Ballen-Barragan A, et al. Acute respiratory distress syndrome and diffuse alveolar damage. new insights on a complex relationship. Ann Am Thorac Soc. 2017 Jun;14(6):844–850.
   PubMedGoogle Scholar
• Otani K, Seo Y, Ogawa K. Radiation-induced organizing pneumonia: a characteristic disease that requires symptom-oriented management. Int J Mol Sci. 2017 Jan 27;18(2):281.
   Google Scholar
• Murai T, Shibamoto Y, Nishiyama T, et al. Organizing pneumonia after stereotactic ablative radiotherapy of the lung. Radiat Oncol. 2012 Aug 1;7(1):123.
   PubMedGoogle Scholar
• Adachi Y, Ozeki K, Ukai S, et al. Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2019 Jun;109(6):700–710.
   PubMedGoogle Scholar
• Haider S, Durairajan N, Soubani AO. Noninfectious pulmonary complications of haematopoietic stem cell transplantation. Eur Respir Rev. 2020 Jun 30;29(156):190119.
   PubMedGoogle Scholar
• Costa AN, Carraro RM, Nascimento EC, et al. Acute fibrinoid organizing pneumonia in lung transplant: the most feared allograft dysfunction. Transplantation. 2016 Mar;100(3):e11–2.
   PubMedGoogle Scholar
• Vanstapel A, Verleden SE, Weynand B, et al. Late-onset “acute fibrinous and organising pneumonia” impairs long-term lung allograft function and survival. Eur Respir J. 2020 Sep;56(3):1902292.
   PubMedGoogle Scholar
• Myers JL. Hypersensitivity pneumonia: the role of lung biopsy in diagnosis and management. Mod Pathol. 2012 Jan;25(Suppl S1):S58–67.
   PubMedGoogle Scholar
• Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of hypersensitivity pneumonitis in adults. an official ats/jrs/alat clinical practice guideline. Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36–e69.
   PubMed Web of Science ®Google Scholar
• Nicholson AG. Classification of idiopathic interstitial pneumonias: making sense of the alphabet soup. Histopathology. 2002 Nov;41(5):381–391.
   PubMedGoogle Scholar
• Rossi G, Cavazza A, Spagnolo P, et al. The role of macrophages in interstitial lung diseases: number 3 in the Series “Pathology for the clinician” Edited by Peter Dorfmuller and Alberto Cavazza. Eur Respir Rev. 2017 Sep 30;26(145):170009.
   PubMed Web of Science ®Google Scholar
• Tazelaar HD, Wright JL, Churg A. Desquamative interstitial pneumonia. Histopathology. 2011 Mar;58(4):509–516.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005 Jan;127(1):178–184.
   PubMed Web of Science ®Google Scholar
• Liebow AA, Steer A, Billingsley JG. Desquamative Interstitial Pneumonia. Am J Med. 1965 Sep;39(3):369–404.
   PubMedGoogle Scholar
• Ghio AJ, Hilborn ED, Stonehuerner JG, et al. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med. 2008 Dec 1;178(11):1130–1138.
   PubMedGoogle Scholar
• You R, Lu W, Shan M, et al. Nanoparticulate carbon black in cigarette smoke induces DNA cleavage and Th17-mediated emphysema. Elife. 2015;4:e09623.
   PubMed Web of Science ®Google Scholar
• Brody AR, Craighead JE. Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers. Lab Invest. 1975 Feb;32(2):125–132. PubMed PMID: 163418.
   PubMed Web of Science ®Google Scholar
• Mohan S, Ho T, Kjarsgaard M, et al. Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study. BMC Pulm Med. 2017 Apr 12;17(1):60.
   PubMedGoogle Scholar
• Pappas RS. Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization. Metallomics. 2011 Nov;3(11):1181–1198.
   PubMed Web of Science ®Google Scholar
• Kumar A, Cherian SV, Vassallo R, et al. Current concepts in pathogenesis, diagnosis, and management of smoking-related interstitial lung diseases. Chest. 2018 Aug;154(2):394–408.
   PubMedGoogle Scholar
• Godbert B, Wissler MP, Vignaud JM. Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology. Eur Respir Rev. 2013 Jun 1;22(128):117–123.
   PubMedGoogle Scholar
• Ishii H, Iwata A, Sakamoto N, et al. Desquamative interstitial pneumonia (DIP) in a patient with rheumatoid arthritis: is DIP associated with autoimmune disorders? Intern Med. 2009;48(10):827–830.
   PubMedGoogle Scholar
• Swartz JS, Chatterjee S, Parambil JG. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis. J Clin Rheumatol. 2010 Sep;16(6):284–286.
   PubMedGoogle Scholar
• Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008 Apr;63(4):366–373.
   PubMedGoogle Scholar
• Lougheed MD, Roos JO, Waddell WR, et al. Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins. Chest. 1995 Nov;108(5):1196–1200.
   PubMed Web of Science ®Google Scholar
• Hamman L, Rich AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc. 1935;51:154–163.
   PubMedGoogle Scholar
• Beasley MB. The pathologist’s approach to acute lung injury. Arch Pathol Lab Med. 2010 May;134(5):719–727.
   PubMedGoogle Scholar
• Leslie KO. My approach to interstitial lung disease using clinical, radiological and histopathological patterns. J Clin Pathol. 2009 May;62(5):387–401.
   PubMedGoogle Scholar
• Ichikado K, Suga M, Muller NL, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med. 2002 Jun 1;165(11):1551–1556.
   PubMed Web of Science ®Google Scholar
• Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007 May-Jun;27(3):595–615.
   PubMedGoogle Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019 Mar 14;5(1):18.
   PubMed Web of Science ®Google Scholar
• Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017 Aug 10;377(6):562–572.
   PubMed Web of Science ®Google Scholar
• Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am. 1973 May;57(3):809–843.
   PubMedGoogle Scholar
• Swigris JJ, Berry GJ, Raffin TA, et al. Lymphoid interstitial pneumonia: a narrative review. Chest. 2002 Dec;122(6):2150–2164.
   PubMedGoogle Scholar
• Koss MN, Hochholzer L, Langloss JM, et al. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology. 1987 Apr;19(2):178–185.
   PubMed Web of Science ®Google Scholar
• Gupta N, Vassallo R, Wikenheiser-Brokamp KA, et al. Diffuse cystic lung disease. Part II. Am J Respir Crit Care Med. 2015 Jul 1;192(1):17–29.
   PubMed Web of Science ®Google Scholar
• Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society. Thorax. 2008 Sep;63(Suppl 5):v1–58.
   PubMed Web of Science ®Google Scholar
• Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1999 Aug;212(2):567–572.
   PubMedGoogle Scholar
• Travis WD, Fox CH, Devaney KO, et al. Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol. 1992 May;23(5):529–541.
   PubMedGoogle Scholar
• van Zyl-smit RN, Naidoo J, Wainwright H, et al. HIV associated Lymphocytic Interstitial Pneumonia: a clinical, histological and radiographic study from an HIV endemic resource-poor setting. BMC Pulm Med. 2015 Apr 22;15(1):38.
   PubMedGoogle Scholar
• Prasoppokakorn T, Assanasen T, Chantranuwatana P, et al. EBV-associated lymphoid interstitial pneumonia in IBD patient: case report and literature review. Respir Med Case Rep. 2020;30:101059.
   PubMedGoogle Scholar
• Wright JA, Pennington JE. Familial lymphoid interstitial pneumonitis. J Pediatr. 1987 Oct;111(4):638.
   PubMedGoogle Scholar
• O’Brodovich HM, Moser MM, Lu L. Familial lymphoid interstitial pneumonia: a long-term follow-up. Pediatrics. 1980 Mar;65(3):523–528. PubMed PMID: 7360539.
   PubMedGoogle Scholar
• Rao N, Mackinnon AC, Routes JM. Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency–histologic and immunohistochemical analyses of 16 cases. Hum Pathol. 2015 Sep;46(9):1306–1314.
   PubMed Web of Science ®Google Scholar
• Davies CW, Juniper MC, Gray W, et al. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax. 2000 Jan;55(1):88–90.
   PubMedGoogle Scholar
• Perreault C, Cousineau S, D’Angelo G, et al. Lymphoid interstitial pneumonia after allogeneic bone marrow transplantation. A possible manifestation of chronic graft-versus-host disease. Cancer. 1985 Jan 1;55(1):1–9.
   PubMedGoogle Scholar
• Chamberlain DW, Hyland RH, Ross DJ. Diphenylhydantoin-induced lymphocytic interstitial pneumonia. Chest. 1986 Sep;90(3):458–460.
   PubMedGoogle Scholar
• Avelino EBP, Verza L, Neves T, et al. Lymphocytic interstitial pneumonia and pulmonary amyloidosis in Sjogren’s syndrome. Radiol Bras. 2019 Nov-Dec;52(6):410–411.
   PubMedGoogle Scholar
• Amitani R, Niimi A, Kuse F. Idiopathic Pulmonary Upper Lobe Fibrosis (IPUF). Kokyu. 1992;11:693–699.
   Google Scholar
• Chua F, Desai SR, Nicholson AG, et al. Pleuroparenchymal fibroelastosis. a review of clinical, radiological, and pathological characteristics. Ann Am Thorac Soc. 2019 Nov;16(11):1351–1359.
   PubMed Web of Science ®Google Scholar
• Frankel SK, Cool CD, Lynch DA, et al. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004 Dec;126(6):2007–2013.
   PubMedGoogle Scholar
• Khiroya R, Macaluso C, Montero MA, et al. Pleuroparenchymal fibroelastosis: a review of histopathologic features and the relationship between histologic parameters and survival. Am J Surg Pathol. 2017 Dec;41(12):1683–1689.
   PubMedGoogle Scholar
• Bonifazi M, Sverzellati N, Negri E, et al. Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact. Eur Respir J. 2020 Jul;56(1):1902135.
   PubMedGoogle Scholar
• Enomoto Y, Nakamura Y, Colby TV, et al. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease. PLoS One. 2017;12(6):e0180283.
   PubMedGoogle Scholar
• Iwai K, Mori T, Yamada N, et al. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med. 1994 Sep;150(3):670–675.
   PubMedGoogle Scholar
• Orlandi M, Landini N, Bruni C, et al. Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review. Rheumatology (Oxford). 2020 Dec 1;59(12):3645–3656.
   PubMedGoogle Scholar
• Bondeelle L, Gras J, Michonneau D, et al. Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 May;55(5):982–986.
   PubMedGoogle Scholar
• Von der Thusen JH, Hansell DM, Tominaga M, et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol. 2011 Dec;24(12):1633–1639.
   PubMedGoogle Scholar
• Pakhale SS, Hadjiliadis D, Howell DN, et al. Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation. J Heart Lung Transplant. 2005 Sep;24(9):1260–1268.
   PubMedGoogle Scholar
• Ofek E, Sato M, Saito T, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol. 2013 Mar;26(3):350–356.
   PubMed Web of Science ®Google Scholar
• Newton CA, Batra K, Torrealba J, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J. 2016 Dec;48(6):1710–1720.
   PubMed Web of Science ®Google Scholar
• Borie R, Bouvry D, Cottin V, et al. Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes. Eur Respir J. 2019 Feb;53(2):1800508.
   PubMedGoogle Scholar
• Watanabe K. Pleuroparenchymal Fibroelastosis: its Clinical Characteristics. Curr Respir Med Rev. 2013 Jun;9:229–237.
   Google Scholar
• Xu L, Rassaei N, Caruso C. Pleuroparenchymal fibroelastosis with long history of asbestos and silicon exposure. Int J Surg Pathol. 2018 Apr;26(2):190–193.
   PubMedGoogle Scholar
• Huang Z, Li S, Zhu Y, et al. Pleuroparenchymal fibroelastosis associated with aluminosilicate dust: a case report. Int J Clin Exp Pathol. 2015;8(7):8676–8679.
   PubMedGoogle Scholar
• Jacob J, Odink A, Brun AL, et al. Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis. Respir Med. 2018 May;138:95–101.
   PubMed Web of Science ®Google Scholar
• Sugino K, Ono H, Watanabe N, et al. Acute exacerbation in chronic bird fancier’s lung with pleuroparenchymal fibroelastosis. Respirol Case Rep. 2021 Jan;9(1):e00693.
   PubMedGoogle Scholar
• Beynat-Mouterde C, Beltramo G, Lezmi G, et al. Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J. 2014 Aug;44(2):523–527.
   PubMedGoogle Scholar
• Chen F, Matsubara K, Miyagawa-Hayashino A, et al. Lung transplantation for pleuroparenchymal fibroelastosis after chemotherapy. Ann Thorac Surg. 2014 Nov;98(5):e115–7.
   PubMedGoogle Scholar
• Goondi D, Franko A, Johannson KA. Pleuroparenchymal Fibroelastosis Post Liver Transplantation. Am J Respir Crit Care Med. 2021 Mar 4. https://doi.org/10.1164/rccm.202009-3432IM.
   Google Scholar
• Kurosaki F, Bando M, Nakayama M, et al. Clinical features of pulmonary aspergillosis associated with interstitial pneumonia. Intern Med. 2014;53(12):1299–1306.
   PubMed Web of Science ®Google Scholar
• Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012 Aug;40(2):377–385.
   PubMedGoogle Scholar
• Chaudhuri N, Spencer L, Greaves M, et al. A review of the multidisciplinary diagnosis of interstitial lung diseases: a retrospective analysis in a single UK specialist centre. J Clin Med. 2016 Jul 27;5(8):66.
   PubMed Web of Science ®Google Scholar
• Grewal JS, Morisset J, Fisher JH, et al. Role of a regional multidisciplinary conference in the diagnosis of interstitial lung disease. Ann Am Thorac Soc. 2019 Apr;16(4):455–462.
   PubMedGoogle Scholar
• Jones KD. Unclassifiable interstitial lung disease: a pathologist’s perspective. Eur Respir Rev. 2018 Mar 31;27(147):170132.
   PubMedGoogle Scholar
• Orr C, Jacobs W. Pulmonary Fibrosis. Radiology. 1926;7(4):318–325.
   Google Scholar
• Takishima T, Shimura S. Definition and classification of pulmonary fibrosis. In: Takishma T, editor. Basic and clinical aspects of pulmonary fibrosis. Boca Raton FL: CRC Press; 1994. p. 293–303.
   Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788–824.
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44–e68.
   PubMed Web of Science ®Google Scholar
• Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997 Jan;155(1):242–248.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Sasaki S, Yokoyama T, et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg. 2005 Apr;49(3):259–265.
   PubMedGoogle Scholar
• Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc. 2006 Jun 3;3(4):293–298.
   PubMedGoogle Scholar
• Ekstrom M, Gustafson T, Boman K, et al. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ Open. 2014 Jan 9;4(1):e004018.
   PubMedGoogle Scholar
• Gulati M, Redlich CA. Asbestosis and environmental causes of usual interstitial pneumonia. Curr Opin Pulm Med. 2015 Mar;21(2):193–200.
   PubMedGoogle Scholar
• King TE Jr., Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29;370(22):2083–2092.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29;370(22):2071–2082.
   PubMed Web of Science ®Google Scholar
• Blanc PD, Annesi-Maesano I, Balmes JR, et al. The occupational burden of nonmalignant respiratory diseases. An official american thoracic society and european respiratory society statement. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1312–1334.
   PubMed Web of Science ®Google Scholar
• Lee CT, Adegunsoye A, Chung JH, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest. 2021 Feb 20. https://doi.org/10.1016/j.chest.2021.02.026.
   Google Scholar
• Copeland CR, Collins BF, Salisbury ML. Identification and remediation of environmental exposures in patients with interstitial lung disease: evidence review and practical considerations. Chest. 2021 Feb 18;160(1):219–230.
   PubMedGoogle Scholar
• Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013 Nov 25;5: 483–492.
   PubMedGoogle Scholar
• Kalafatis D, Gao J, Pesonen I, et al. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden. BMC Pulm Med. 2019 Nov 27;19(1):222.
   PubMedGoogle Scholar
• Fang C, Huang H, Zhang Q, et al. Relation between sex hormones and leucocyte telomere length in men with idiopathic pulmonary fibrosis. Respirology. 2020 Dec;25(12):1265–1273.
   PubMedGoogle Scholar
• Kreuter M, Raghu G. Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent. Eur Respir J. 2018 Jun;51(6):1800921.
   PubMedGoogle Scholar
• Ghisa M, Marinelli C, Savarino V, et al. Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag. 2019;15:1081–1093.
   PubMed Web of Science ®Google Scholar
• Kropski JA, Blackwell TS, Loyd JE. The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J. 2015 Jun;45(6):1717–1727.
   PubMedGoogle Scholar
• Allen RJ, Guillen-Guio B, Oldham JM, et al. Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2020 Mar 1;201(5):564–574.
   PubMed Web of Science ®Google Scholar
• Schwartz DA. Idiopathic pulmonary fibrosis is a genetic disease involving mucus and the peripheral airways. Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S192–S197. PubMed PMID: 30431344; PubMed Central PMCID: PMCPMC6322034.
   PubMedGoogle Scholar
• Spagnolo P, Cottin V. Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine. J Med Genet. 2017 Feb;54(2):93–99. PubMed PMID: 28011761.
   PubMedGoogle Scholar
• Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010 Jun;356:1322–1328. PubMed PMID: 19996193
   PubMed Web of Science ®Google Scholar
• Wuyts WA, Cavazza A, Rossi G, et al. Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic? Eur Respir Rev. 2014 Sep;23133:308–319. PubMed PMID: 25176967
   PubMedGoogle Scholar
• Basseri B, Enayati P, Marchevsky A, et al. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis. 2010 Oct;44:390–397. PubMed PMID: 21122534
   PubMedGoogle Scholar
• Jankowich MD, Rounds SIS. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest. 2012 Jan;141(1):222–231. PubMed PMID: 22215830; PubMed Central PMCID: PMCPMC3251269.
   PubMed Web of Science ®Google Scholar
• Lucas RM, McMichael AJ. Association or causation: evaluating links between “environment and disease”. Bull World Health Organ. 2005 Oct;83(10):792–795. PubMed PMID: 16283057; PubMed Central PMCID: PMCPMC2626424.
   PubMedGoogle Scholar
• Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019 Oct 31;381(18):1718–1727. PubMed PMID: 31566307.
   PubMed Web of Science ®Google Scholar
• Behr J, Prasse A, Kreuter M, et al. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med. 2021 May;95:476–486. PubMed PMID: 33798455
   PubMed Web of Science ®Google Scholar
• McCrae K. Immune thrombocytopenia: no longer ‘idiopathic’. Cleve Clin J Med. 2011 Jun;78(6):358–373. PubMed PMID: 21632906; PubMed Central PMCID: PMCPMC3410635.
   PubMedGoogle Scholar
• Mullen SA, Berkovic SF, Commission IG. Genetic generalized epilepsies. Epilepsia. 2018 Jun;59(6):1148–1153. PubMed PMID: 29741207.
   PubMedGoogle Scholar
• Raj MA, Ranka S, Goyal A. Hypertrophic obstructive cardiomyopathy. StatPearls. Treasure Island (FL); 2021.
   Google Scholar
• Ferrario F, Tadros M, Napodano P, et al. Rapidly progressive glomerulonephritis (RPGN): is there still an “idiopathic” subgroup? Adv Exp Med Biol. 1993;336:431–434. PubMed PMID: 8296650.
   PubMedGoogle Scholar